AIxCrypto Holdings, Inc.
- AIXC
- NASDAQ
- Infrastructure software
- Oncology Biotech
- Small Molecule Drugs
$1.37
Today +21.24%Quote Oct 6, 2026, 05:56 PM UTC
+67.30%over the last month
Max drawdown −41.6%From 1-month high −16.7%3 months +51.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About AIxCrypto
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors.
Sector
Technology
Industry
Infrastructure software
Exchange
NASDAQ
Employees
10
Founded
1996
Market value
$27.7M
Quote Oct 6
Floor
$1.36
0.4% below price
Resistance
$1.63
18.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AIXCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free